MEETINGS - Seminar on Medical device reimbursement in Europe (UK) October 2001:
This article was originally published in Clinica
Management Forum is holding a seminar on Medical device reimbursement in Europe at The Cavendish Hotel, London on October 29 2001. The seminar is aimed at those interested in sales and marketing, reimbursement, business development, clinical research, outcome research, health economics, regulatory affairs and finance. Amongst the guest speakers is Dr Christian VanderVelde, director of Novoste. Attendance is restricted to 40 participants. For further information contact: +44 (0)1483 536424; email: firstname.lastname@example.org www.management-forum.co.uk
You may also be interested in...
Orladeyo is the first oral prophylactic approved in the US for hereditary angioedema, with Japan and EU approvals expected to follow. Pricing of $485,000 a year undercuts segment leader.
Results of Study to Assess Statin Residual Risk with Epanova in High Cardiovascular Risk Patients with Hypertriglyceridemia “should prompt reconsideration of [OTC] mixed omega-3 fatty acid products for [atherosclerotic cardiovascular disease] prevention,” say cardiologists in an editorial published with JAMA study.
In a final guidance from the US agency, regulators say most combination product questions are best resolved through traditional pathways and noted that initiating a so-called combination product agreement meeting may be unproductive.